These findings suggest that GLP-1 RAs could serve as an alternative to bariatric surgery for weight management prior to THA, potentially mitigating surgical risks associated with obesity. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.